Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 994 of 5804
-
Can plasma repair Sepsis-Damaged blood vessels? new trial aims to find out
Disease control Not yet recruitingSepsis damages the blood vessel lining and its protective "glycocalyx," contributing to organ failure and death. This pilot, randomized, blinded study will test whether giving fresh frozen plasma (FFP)-either as intermittent boluses or as a continuous infusion-protects or repairs…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a heart procedure cut stroke risk after valve repair? new trial aims to find out
Disease control Not yet recruitingCABA-MiTRA-AFNET12 is a non-commercial, parallel-group, prospective, randomised, open, blinded endpoint assessment (PROBE), multi-centre, therapy strategy trial. The trial investigates patients with severe mitral valve regurgitation who have undergone transcatheter edge-to-edge m…
Phase: NA • Sponsor: Atrial Fibrillation Network • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis research is being done to test a combination of two drugs, Izalontamab Brengitecan (iza-bren) and Adagrasib, in patients with advanced KRAS G12C-mutant NSCLC that hasn't responded to other treatments. The purpose is to see if this combination works better than existing treat…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Asthma showdown: which inhaler strategy wins?
Disease control Not yet recruitingThe goal of this trial test two known effective asthma strategies. Treatment guidelines recommend combination therapy of inhaled corticosteroids (ICS) with a long-acting beta-agonist (LABA) inhaled medications. This strategy is known as MART (maintenance and reliever therapy). Th…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug aims to starve prostate cancer by blocking testosterone
Disease control Not yet recruitingThe purpose of this clinical trial is to test the effectiveness of a dosing regimen of Teverelix DP castration rate defined as the cumulative probability of testosterone suppression to \< 0.5 ng/mL with the lower bound of the 95% confidence interval (CI) being \> 90% to meet the …
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a disc made from donated tissue ease severe dry eye?
Disease control Not yet recruitingTo evaluate the efficacy of Lyophilized Human Amnion Membrane Disc in reducing corneal epithelial damage as measured by the Lexitas Modified National Eye Institute (NEI) Grading Scale for Corneal Fluorescein Staining.
Phase: PHASE3 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New ultrasound could spot heart danger in cancer patients
Diagnosis Not yet recruitingInflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. A new class of medications used for cancer called immune checkpoint inhibitors (ICI) work by increasing the body's inflammmation respons…
Phase: EARLY_PHASE1 • Sponsor: University of Virginia • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
Acupuncture with a jolt: new trial tests electric needles for cancer brain fog
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the clinical effectiveness and understand the biological mechanisms of electroacupuncture (EA) in reducing cognitive toxicity among cancer survivors. The study aims are: * To evaluate the clinical effectiveness of a 10-week EA regim…
Phase: PHASE3 • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can a common cholesterol pill flush out 'forever chemicals' from veterans' bodies?
Disease control Not yet recruitingThe goal of this study is to test the efficacy and feasibility of Colesevelam administration (50% of the recommended dose) to reduce serum PFAS concentration in the Veteran population who have serum PFAS levels that exceed the National Academies Science criteria (PFASsix \> 20 ng…
Phase: PHASE2 • Sponsor: University of Rhode Island • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a common vitamin help fight sepsis? new trial aims to find out
Disease control Not yet recruitingSepsis is a severe, life-threatening condition caused by an abnormal host response to infection, which includes systemic inflammation, oxidative stress, and increasing organ dysfunction. It is frequently associated with bacterial, viral, fungal, or parasite infections, as well as…
Phase: PHASE4 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could air make bladder exams clearer during active bleeding?
Diagnosis Not yet recruitingMacroscopic haematuria is a common urological emergency. Diagnostic cystoscopy is the gold standard for identifying the bleeding source; however, blood and clots within the bladder significantly impair endoscopic visibility when saline is used as the distension medium. Air-based…
Phase: NA • Sponsor: Kantonsspital Baden • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Seated tai chi tested as a way to boost heart health in women with limited mobility
Disease control Recruiting nowREVIVE is a randomized controlled trial designed to evaluate the effects of a remotely delivered seated Tai Chi/Qigong (TCQ) intervention on cardiometabolic health, stress, sleep, and psychological well-being among women with mobility impairments. Women with mobility impairments…
Phase: NA • Sponsor: Arizona State University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Simple blood tests could spot liver cancer earlier in diabetics
Disease control Not yet recruitingLiver cancer is a significant malignancy in Taiwan. With the widespread implementation of antiviral therapies, hepatitis B and C-related liver cancer has gradually declined; however, metabolic dysfunction-associated liver cancer continues to increase, particularly among patients …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New pain block cocktail may cut opioid use after breast surgery
Symptom relief Not yet recruitingA large number of patients undergoing major surgical procedures for the management of breast cancer complain of acute and chronic postoperative pain. Morphine administration for acute pain after mastectomy surgery has many side effects. Regional block techniques, such as paravert…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Ancient cupping therapy put to the test for ringing ears
Symptom relief Not yet recruitingCupping therapy is an ancient complementary medicine therapy. It was a cornerstone in many ancient healing systems, including Traditional Chinese Medicine, Unani Medicine, Traditional Korean Medicine, and Islamic Medicine. Previous pilot randomized controlled trials reported prom…
Phase: NA • Sponsor: Hamad Medical Corporation • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Common allergy drug may heal brain damage in preterm infants
Disease control Not yet recruitingThe researchers are investigating a new treatment for white matter injury, which is a common type of brain injury in premature babies. The drug, clemastine, is experimental. This means that the drug is not approved by the Food and Drug Administration (FDA) for the treatment of wh…
Phase: PHASE1 • Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New Wound-Cleaning method may let surgeons close incisions right away after severe appendicitis
Disease control Not yet recruitingThe goal of this clinical trial is to compare primary wound closure (PC) versus delayed primary closure (DPC) after standardized wound decontamination using the High-Efficiency Incision and Drainage with Irrigation (HIEDI) technique in patients undergoing open appendectomy for co…
Phase: NA • Sponsor: Sana'a University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Dentist visit could catch hidden diabetes risk
Diagnosis Recruiting nowThis study will evaluate whether HbA1c screening can be performed in dental care to detect elevated blood glucose in patients with advanced periodontitis and support referral to primary care. Periodontitis is a common chronic inflammatory disease affecting the supporting tissues…
Phase: NA • Sponsor: Region Skane • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New pill targets cancer growth at the genetic level
Disease control Not yet recruitingThis is an open-label, multicenter Phase 1 first-in-human trial of SYH2095, a selective KAT6A/B inhibitor. The trail contains two segments: Part 1A dose escalation and Part 2A cohort expansion. Part 1A uses the BOIN dose-escalation design, enrolling patients with advanced maligna…
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a daily eating window shield kidneys in diabetes?
Disease control Recruiting nowThis is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eatin…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC